More Than 80,900 Tandem Mobi Insulin Pumps Affected by False Occlusion Alarms That Can Interrupt Insulin Delivery, Cause Dangerous Blood Sugar Levels, and Lead to Hospitalization.


What Parker Waichman LLP Found

  • More than 80,900 devices affected: Tandem issued a correction involving Mobi insulin pumps distributed primarily in the United States.
  • 230 reported adverse events: The manufacturer received reports involving medical intervention or hospitalization as of October 29.
  • Insulin delivery interruptions: False occlusion alarms can suspend insulin administration until users respond and resume therapy.
  • Potential mechanical problem: Increased friction within the pump’s drive module may trigger false alarms.
  • Possible product liability lawsuits: Patients injured by an alleged device defect may have claims against the manufacturer if they can establish defect, causation, and damages.

Thousands of people with diabetes depend on insulin pumps to deliver carefully controlled amounts of insulin throughout the day and night. These medical devices help patients manage blood glucose levels without relying exclusively on repeated manual injections. When an insulin pump malfunctions, however, an interruption in insulin delivery can quickly become a serious medical emergency, particularly for individuals who depend on continuous insulin administration.

Tandem Diabetes Care has issued a medical device correction affecting more than 80,900 Tandem Mobi insulin pumps following reports that certain devices may generate false occlusion alarms. According to an October 30 entry in the U.S. Food and Drug Administration’s recall database, these alarms can suspend insulin delivery until the user acknowledges the warning and resumes therapy.

As of October 29, Tandem had received reports of 230 adverse events requiring medical intervention or hospitalization. No deaths had been reported. The correction began in late September, and the FDA’s recall database identified potentially affected devices.

For patients who experienced severe hyperglycemia, diabetic ketoacidosis, hospitalization, or other complications potentially associated with interrupted insulin delivery, the recall raises important questions about medical device safety and potential product liability claims.

How the Tandem Mobi Insulin Pump Malfunction Can Interrupt Insulin Delivery

The Tandem Mobi insulin pump is designed to administer insulin through a controlled delivery system. An occlusion alarm ordinarily warns patients that insulin flow may be obstructed, allowing them to investigate a potential blockage or delivery problem.

The reported malfunction creates a different concern. According to the FDA recall information described in the report, increased friction within the pump’s drive module can reduce available motor power. Under certain conditions, the motor may operate below the device’s occlusion detection threshold, causing an alarm even when an actual obstruction is not present.

When the alarm activates, insulin delivery stops until the user acknowledges the warning and resumes therapy. Repeated false alarms may cause additional interruptions, potentially leaving patients without sufficient insulin for extended periods.

This problem is especially concerning during sleep, work, exercise, or other circumstances when users may not immediately recognize an alarm. Although an alarm is intended to provide a safety warning, a malfunction that repeatedly suspends therapy can create a separate medical hazard.

Dangerous Hyperglycemia and Diabetic Ketoacidosis Following Insulin Pump Interruptions

Insulin is essential for regulating blood glucose levels. When an insulin pump unexpectedly stops administering insulin, blood sugar may rise, sometimes rapidly. The medical consequences depend on the patient’s condition, the duration of the interruption, and whether alternative insulin treatment is available.

Hyperglycemia, or elevated blood glucose, can cause excessive thirst, frequent urination, fatigue, blurred vision, and dehydration. More serious insulin deficiencies can lead to diabetic ketoacidosis (DKA), particularly in people with type 1 diabetes.

DKA develops when insufficient insulin causes the body to break down fat for energy, producing ketones that can accumulate and make the blood dangerously acidic. Symptoms may include nausea, vomiting, abdominal pain, rapid breathing, confusion, and severe dehydration.

Without prompt treatment, DKA can cause life-threatening complications requiring emergency hospitalization or intensive care. Patients experiencing persistent high blood glucose, elevated ketones, vomiting, or other warning signs should follow their emergency diabetes treatment instructions and obtain urgent medical attention when indicated.

The reported recall does not establish that every adverse event involved DKA or permanent injury. Nevertheless, interruptions in insulin administration present a medically significant risk that warrants careful investigation when patients suffer serious complications.

Why the FDA Recall Raises Questions About Insulin Pump Safety

The FDA’s recall database identifies more than 80,900 Tandem Mobi devices associated with the correction. Although certain serial numbers were identified for exchange because of frequent false alarms, the recall information also indicates that all affected pump models and serial numbers may experience the problem.

The distinction is important for patients who have not experienced repeated alarms. A device may fall within the affected population even when the user has not previously encountered a malfunction.

Tandem has advised customers that they may continue using their Mobi pumps while following the company’s safety instructions. Users are instructed to respond to occlusion alarms, maintain an alternative method of insulin delivery, and contact customer support if repeated alarms continue despite troubleshooting.

Patients should not independently discontinue prescribed insulin therapy because of the recall. Instead, they should coordinate with their diabetes care providers to determine appropriate backup insulin arrangements and follow the manufacturer’s current correction instructions.

Tandem is investigating the mechanical issue and has reported changes to its testing procedures intended to prevent similar problems in the future.

Previous Tandem Mobi Software Problems Raise Additional Product Safety Concerns

The latest correction follows an earlier Tandem Mobi recall involving a separate software malfunction that could affect insulin delivery. According to the reporting, Tandem notified customers about that issue in October 2025 and instructed them to install a software update. The FDA subsequently posted the earlier correction in its recall database in April.

Although the two corrections involve different reported problems, they demonstrate the importance of dependable insulin pump hardware and software. Patients depend on these systems to deliver medication consistently, provide accurate warnings, and operate safely under ordinary conditions.

A history of corrections does not independently establish that a manufacturer was negligent or that a particular device caused a patient’s injuries. However, prior warnings, design changes, testing records, and manufacturer communications may become relevant evidence when investigating whether a product was reasonably safe.

Can Patients File a Tandem Mobi Insulin Pump Product Liability Lawsuit?

Patients who suffered injuries potentially associated with interrupted insulin delivery may have grounds to investigate a product liability lawsuit. Depending on applicable state law and the evidence, potential claims may involve defective design, manufacturing defects, inadequate warnings, or other legally recognized theories.

A defective design claim may examine whether the pump’s drive mechanism created an unreasonable risk of interrupted insulin delivery. A manufacturing defect claim may investigate whether an individual device departed from its intended specifications. Warning-related claims may examine whether patients and healthcare providers received legally adequate information about known or reasonably foreseeable risks.

Medical device litigation can also involve federal regulatory requirements and preemption defenses. Whether a particular claim is legally available depends in part on the device’s regulatory status and the specific allegations.

A recall alone does not prove liability. Patients generally must establish an actionable defect or other legal violation, a causal connection to their injuries, and legally compensable damages.

Compensation for Harm Caused by a Defective Insulin Pump

When a defective insulin pump causes serious medical complications, injured patients may incur substantial medical expenses. Emergency treatment, hospitalization, intensive care, diagnostic testing, and ongoing medical monitoring can create significant financial burdens.

Depending on the applicable law and circumstances, compensation may include medical expenses, lost wages, diminished earning capacity, physical pain, emotional suffering, and other recoverable losses.

Patients should preserve medical records, pump alarm histories, glucose monitoring information, communications with Tandem, and documentation identifying the device model and serial number. These materials may help establish when insulin delivery was interrupted and whether the malfunction contributed to a medical emergency.

Tandem Mobi Insulin Pump Recall Lawsuit FAQs

Can I sue Tandem Diabetes Care if my insulin pump stopped delivering insulin?

You may have grounds to pursue a product liability claim if a defect or other actionable failure caused an interruption in insulin delivery and resulted in injury. The FDA recall and reported adverse events may support further investigation, but they do not automatically establish liability. Medical records, device information, and evidence connecting the malfunction to your injuries are important.

What injuries may qualify for a Tandem Mobi insulin pump lawsuit?

Potential injuries include severe hyperglycemia, diabetic ketoacidosis, dehydration, hospitalization, and complications resulting from insufficient insulin delivery. The severity of the medical condition and evidence of causation are important considerations. A patient who experienced an alarm without physical injury may have a different legal position from someone who required emergency treatment.

Do I need to have been hospitalized to file a lawsuit?

Hospitalization is not necessarily required to investigate a claim. However, a viable personal injury lawsuit generally requires proof of legally recognized harm. Emergency medical treatment, documented physical complications, and related financial losses may be relevant even when a patient was not admitted to the hospital.

Does the recall mean every Tandem Mobi insulin pump is defective?

No. The correction affects a defined population of devices, but inclusion in a recall does not establish that every individual pump malfunctioned. Patients should check their device information against the manufacturer’s current recall instructions and contact Tandem or their healthcare provider when necessary.

Should I stop using my Tandem Mobi insulin pump immediately?

Tandem’s reported instructions permit continued use while following specific safety precautions, including responding to alarms and maintaining backup insulin delivery. Patients should not stop insulin treatment without appropriate medical guidance. Anyone experiencing repeated alarms or unstable glucose levels should contact their diabetes care provider promptly.

What evidence should I preserve for a defective insulin pump claim?

Preserve the pump, serial number, alarm records, continuous glucose monitoring data, medical records, hospital bills, and communications with the manufacturer. If the device must be exchanged, ask about preserving relevant information and documenting its condition before transfer. An attorney can advise on evidence preservation without interfering with necessary medical care.

Can I file a lawsuit if Tandem replaces my recalled insulin pump?

Receiving a replacement does not necessarily eliminate a patient’s legal rights. A replacement may address future device safety, while a personal injury claim concerns harm allegedly caused before the correction. Whether compensation is available depends on the injury, applicable law, and proof of causation.

How long do I have to file a Tandem Mobi insulin pump lawsuit?

Product liability filing deadlines vary by state and may depend on when an injury occurred or was discovered. Certain claims may also involve additional legal restrictions. Patients should seek a timely legal assessment because waiting can make it more difficult to preserve device records and other important evidence.

Contact Parker Waichman LLP About a Tandem Mobi Insulin Pump Injury Lawsuit

Patients who depend on insulin pumps should be able to trust that their medical devices will deliver medication consistently and provide reliable safety warnings. When a device malfunction interrupts insulin administration, the resulting complications can require emergency treatment, hospitalization, and substantial ongoing medical care.

Parker Waichman LLP is a national personal injury law firm representing individuals harmed by allegedly defective medical devices and dangerous consumer products. The firm investigates potential product liability claims involving medical device malfunctions, inadequate warnings, and preventable injuries.

If you or a loved one experienced severe hyperglycemia, diabetic ketoacidosis, hospitalization, or another serious medical complication potentially associated with a Tandem Mobi insulin pump malfunction, Parker Waichman LLP can review the circumstances and discuss your legal options.

Call 1-800-YOUR-LAWYER (1-800-968-7529) for a free consultation. Regardless of your location or where your injury occurred, our nationwide product injury law firm is ready to assist you.

 

SHARE:
Free Consultation

Parker Waichman LLP

Untitled(Required)

CATEGORIES
Parker Waichman Reviews

4.8 from 549 Reviews

Related Testimonials

Our law firm is ready to represent you in your injury case. We’ve helped many New York residents as well as those needing help nationwide. Contact our team for a free case consultation today.

We Have Many Locations To Serve You
Serving Mass Tort Clients Nationally

We have the experience and the skilled litigators to win your case. Contact us and speak with a real attorney who can help you.

Parker Waichman LLP
6 Harbor Park Drive
Port Washington, NY 11050
(516) 466-6500
Parker Waichman LLP
201 Old Country Road – Suite 145
Melville, NY 11747
(631) 390-0800
Parker Waichman LLP
59 Maiden Lane, 6th Floor
New York, NY 10038
(212) 267-6700
Parker Waichman LLP
118-35 Queens Boulevard, Suite 400
Forest Hills, NY 11375
(718) 469-6900
Parker Waichman LLP
300 Cadman Plaza West
One Pierrepont Plaza, 12th Floor
Brooklyn, NY 11201
(718) 554-8055
Parker Waichman LLP
27299 Riverview Center Boulevard, Suite 108
Bonita Springs, FL 34134
(239) 390-1000
Parker Waichman LLP
80 Main Street, Suite 265
West Orange, NJ 07052
(973) 323-3603
Nationwide Service

We handle mass torts cases nationwide. Please contact our office to learn more.

Call Us